Article
Towards Electronic Product Information (ePI) That Meets the Needs of Everyone
By CISCRP Staff|Aug 12, 2025
Abstract
In an age of increasing digitisation, pharmaceutical product information is evolving. This transformation reflects growing recognition among regulators of the value of patient engagement and widespread societal calls for increased transparency of and access to medical information. We consider the future of pharmaceutical product information, reimagining the electronic product information (ePI) as an interoperable and informative platform that links core product information to a range of supporting medical information resources. We consider the benefits that this evolution can afford different stakeholder groups in terms of increased transparency, enriched information provision, and tailored information solutions, as well as the potential challenges that will need to be addressed. We also discuss the critical role that medical writers can play in informing and shaping the future of ePI for the benefit of all.
Key Takeaways:
-
1.
Enhanced Accessibility and Transparency
Electronic product information (ePI) transforms traditional drug leaflets into digital platforms that are searchable, multilingual, and adaptable—making medical information more accessible and transparent for patients, caregivers, and healthcare professionals.
-
2.
Support for Health Equity and Informed Decision-Making
ePI enables tailored information delivery, real-time safety updates, and integration with trusted resources, helping users make better-informed decisions and promoting equitable access to healthcare information.
-
3.
Medical Writers as Key Contributors
Medical writers play a vital role in shaping ePI by creating inclusive, discoverable, and user-friendly content, ensuring that digital health communication meets the diverse needs of all stakeholders.
